Omar Soler‐Cedeño

433 total citations
17 papers, 279 citations indexed

About

Omar Soler‐Cedeño is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Omar Soler‐Cedeño has authored 17 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cellular and Molecular Neuroscience, 6 papers in Molecular Biology and 6 papers in Cognitive Neuroscience. Recurrent topics in Omar Soler‐Cedeño's work include Neuroscience and Neuropharmacology Research (10 papers), Neurotransmitter Receptor Influence on Behavior (7 papers) and Stress Responses and Cortisol (4 papers). Omar Soler‐Cedeño is often cited by papers focused on Neuroscience and Neuropharmacology Research (10 papers), Neurotransmitter Receptor Influence on Behavior (7 papers) and Stress Responses and Cortisol (4 papers). Omar Soler‐Cedeño collaborates with scholars based in United States, Puerto Rico and United Kingdom. Omar Soler‐Cedeño's co-authors include James T. Porter, Marian T. Sepulveda-Orengo, Emmanuel Cruz, Marangelie Criado‐Marrero, Zheng‐Xiong Xi, Caiying Guo, Tianyi Mao, Haining Zhong, Guang Yang and Maozhen Qin and has published in prestigious journals such as Journal of Neuroscience, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Omar Soler‐Cedeño

15 papers receiving 276 citations

Peers

Omar Soler‐Cedeño

CMN

PHYSI

Harold L. Haun United States

Juliana Carlota Kramer Soares Brazil

Brian H. Trieu United States

Stephanie L. Foster United States

Carolina Piletti Chatain Germany

Kristina Valentinova France

Francisco Tomás Gallo Argentina

Huiwen Zhu China

Vorani Ramachandra United States

Emma Cahill United Kingdom

Harold L. Haun United States

Omar Soler‐Cedeño

276 ×1.5

CMN

109 ×0.9

117 ×1.6

65 ×1.3

53 ×1.2

PHYSI

Citations per year, relative to Omar Soler‐Cedeño Omar Soler‐Cedeño (= 1×) peers Harold L. Haun

Countries citing papers authored by Omar Soler‐Cedeño

Since Specialization

Citations

This map shows the geographic impact of Omar Soler‐Cedeño's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omar Soler‐Cedeño with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omar Soler‐Cedeño more than expected).

Fields of papers citing papers by Omar Soler‐Cedeño

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Omar Soler‐Cedeño. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omar Soler‐Cedeño. The network helps show where Omar Soler‐Cedeño may publish in the future.

Co-authorship network of co-authors of Omar Soler‐Cedeño

This figure shows the co-authorship network connecting the top 25 collaborators of Omar Soler‐Cedeño. A scholar is included among the top collaborators of Omar Soler‐Cedeño based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Omar Soler‐Cedeño. Omar Soler‐Cedeño is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Soler‐Cedeño, Omar, et al.. (2025). ESG‐1‐60 and ESG‐1‐61: Novel dopamine D₃ receptor‐preferring partial agonists/antagonists that inhibit cocaine taking and seeking in rodents. British Journal of Pharmacology. 182(13). 2997–3016. 1 indexed citations

Soler‐Cedeño, Omar, Hai‐Ying Zhang, Guo‐Hua Bi, et al.. (2025). Brain CB2 receptor: a new target in medication development for treating opioid use disorder in rodents. Molecular Psychiatry. 31(4). 2351–2364.

Soler‐Cedeño, Omar, Ewa Galaj, Jianjing Cao, et al.. (2025). RDS-04-010: a novel atypical DAT inhibitor that inhibits cocaine taking and seeking and itself has low abuse potential in experimental animals. Translational Psychiatry. 15(1). 182–182.

Soler‐Cedeño, Omar, et al.. (2024). AM6527, a neutral CB1 receptor antagonist, suppresses opioid taking and seeking, as well as cocaine seeking in rodents without aversive effects. Neuropsychopharmacology. 49(11). 1678–1688. 6 indexed citations

Song, Rui, Omar Soler‐Cedeño, & Zheng‐Xiong Xi. (2024). Optical Intracranial Self-Stimulation (oICSS): A New Behavioral Model for Studying Drug Reward and Aversion in Rodents. International Journal of Molecular Sciences. 25(6). 3455–3455. 1 indexed citations

He, Yi, Hui Shen, Guo‐Hua Bi, et al.. (2024). GPR55 is expressed in glutamate neurons and functionally modulates drug taking and seeking in rats and mice. Translational Psychiatry. 14(1). 101–101. 7 indexed citations

Adke, Anisha P., et al.. (2023). Parabrachial To Central Amygdala Pathway Is Essential For Injury-Induced Hypersensitivity. Journal of Pain. 24(4). 13–14. 1 indexed citations

Wilson, Torri D., Anisha P. Adke, Jenny J. Lin, et al.. (2023). The parabrachial to central amygdala pathway is critical to injury-induced pain sensitization in mice. Neuropsychopharmacology. 49(3). 508–520. 28 indexed citations

Sanchez, Julie, Alessandro Bonifazi, Anver Basha Shaik, et al.. (2023). Dopamine D₃/D₂ Receptor Ligands Based on Cariprazine for the Treatment of Psychostimulant Use Disorders That May Be Dual Diagnosed with Affective Disorders. Journal of Medicinal Chemistry. 66(3). 1809–1834. 9 indexed citations

10.

Soler‐Cedeño, Omar & Zheng‐Xiong Xi. (2022). Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge. Cells. 11(20). 3262–3262. 14 indexed citations

11.

Wilson, Torri D., Spring Valdivia, Jun Ma, et al.. (2022). An inhibitory circuit from central amygdala to zona incerta drives pain-related behaviors in mice. eLife. 11. 17 indexed citations

12.

Soler‐Cedeño, Omar, et al.. (2019). Plasticity of NMDA Receptors at Ventral Hippocampal Synapses in the Infralimbic Cortex Regulates Cued Fear. eNeuro. 6(2). ENEURO.0354–18.2019. 20 indexed citations

13.

Criado‐Marrero, Marangelie, et al.. (2017). Dynamic expression of FKBP5 in the medial prefrontal cortex regulates resiliency to conditioned fear. Learning & Memory. 24(4). 145–152. 23 indexed citations

14.

Soler‐Cedeño, Omar, Emmanuel Cruz, Marangelie Criado‐Marrero, & James T. Porter. (2016). Contextual fear conditioning depresses infralimbic excitability. Neurobiology of Learning and Memory. 130. 77–82. 24 indexed citations

15.

Cruz, Emmanuel, et al.. (2015). Infralimbic EphB2 Modulates Fear Extinction in Adolescent Rats. Journal of Neuroscience. 35(36). 12394–12403. 15 indexed citations

16.

Fortin, Dale A., Shane Tillo, Guang Yang, et al.. (2014). Live Imaging of Endogenous PSD-95 Using ENABLED: A Conditional Strategy to Fluorescently Label Endogenous Proteins. Journal of Neuroscience. 34(50). 16698–16712. 56 indexed citations

17.

Sepulveda-Orengo, Marian T., et al.. (2013). Fear Extinction Induces mGluR5-Mediated Synaptic and Intrinsic Plasticity in Infralimbic Neurons. Journal of Neuroscience. 33(17). 7184–7193. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact